GPhA Requests More Time to Comment on Proposed Labeling Rule

Drug Industry Daily
A A
The FDA’s proposed new labeling requirements for generics pose such a challenge to industry that GPhA has asked the FDA for an additional two months to comment on the proposed rule.

To View This Article:

Login

Subscribe To Drug Industry Daily